IP Library Granted Patent US 10,029,229
Granted Patent B2
US 10,029,229 · App. 14/792,877 · Granted Jul 24, 2018

Adjustable chromophore compounds and materials incorporating such compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,029,229
App. No.
14/792,877
Granted
Jul 24, 2018
Kind
B2
Abstract

The present invention is directed to adjustable chromophore compounds and materials (e.g., ophthalmic lens materials) incorporating those compounds. The adjustable chromophore compounds include a chemical moiety that structurally changes upon exposure to predetermined electromagnetic radiation (e.g., two photon radiation) as well as lens materials, particularly intraocular lens materials that incorporate those compounds.

Claims (9)

1. A method of adjusting the light absorption characteristics of an intraocular lens, the method comprising:

implanting into a patient a lens having a compound selected from the group consisting of:

wherein W is an electron withdrawing moiety;

D is an electron donating moiety; and

Z is a mobilization inhibiting moiety; and

exposing the lens to electromagnetic radiation sufficient to adjust the amount of UV light, blue light, or both that the lens absorbs.

2. The method of claim 1 wherein W is selected from the group consisting of Cl, F, and CF 3 .

3. The method of claim 1 wherein D is selected from the group consisting of alkyl, alkoxy, and amino groups.

4. The method of claim 1 wherein Z is selected from the group consisting of unsubstituted or substituted C 4 -C 20 alkyl.

Assignments (3)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2015
From: WEINSCHENK, JOSEPH I., III.
To: ALCON, INC.
Reel/Frame 036007/0763 →
MERGER Recorded Jul 7, 2015
From: ALCON, INC.
To: NOVARTIS AG
Reel/Frame 036009/0200 →